Perspective · 29 Jan 2025
Research articlePublished 6 Aug 2018
Comparing Two Year Survival Rate of Esophageal Cancer Patients with and without Neoadjuvant Chemoradiotherapy Treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aim: This study was designed with the aim of determining and comparing the two year survival rate of patients who had, and had not received neoadjuvant chemoradiotherapy. Methods: This analytical study, approved by the ethical committee of Urmia University of Medical Sciences, evaluated esophageal cancer patients who had undergone surgery in Imam Khomeini Hospital of Urmia, between the years 2011 and 2016. Subjects were analyzed as two groups: those who were treated with neoadjuvant methods (n=168) and those who had not received this treatment (n=112). Results: The most common symptom in patients was dysphagia in each group (90.4% versus 87.5%) and also the most common types of esophagus cancer in our study was SCC in each group (88% versus 91.07%). A significant variation concerning survival rates between the two groups were observed (P=0.031). According to the Kaplan Meier survival analysis, the average survival rate of the first group (received neoadjuvant chemoradiotherapy) was 42.96 ± 2.74 months and that of the second group (untreated) was 41 ± 3.12 months. It is revealed that a significant variation is present between the two year survival rates of the two study groups (P=0.03). A significant variation was observed between the two groups concerning two year survival rates (P=0.01). Conclusion: Considering the gathered results, our study reveals that pre-operational neoadjuvant chemoradiotherapy is beneficial for the survival rates of patients suffering from esophageal cancer, therefore we recommend that prior to performing invasive treatments, such as surgery, it is beneficial to provide chemoradiotherapy for these patients.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Archives of Medicine.
Perspective · 29 Jan 2025
Early-life nutrition and its impact on pediatric immune development
Commentary · 29 Jan 2025
Polypharmacy in the aging population: Risks, benefits and alternatives
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Mokhtari SAS”
- BylineArticles whose byline prints “Mahmodlou R”
- BylineArticles whose byline prints “Ebrahimi H”
- BylineArticles whose byline prints “Shojaei PS”
